Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -68.72% vs 2.09% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
YoY Growth in year ended Mar 2025 is -7.18% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is NA vs NA in Mar 2024
Compare Balance Sheet Results of Johnson Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
55.00
6.01
48.99
815.14%
Share Warrants & Outstandings
Total Reserve
1.17
15.51
-14.34
-92.46%
Shareholder's Funds
56.17
21.53
34.64
160.89%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.61
0.00
0.61
0.00%
Secured Loans
0.61
0
0.61
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.60
-0.60
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.53
-0.53
-100.00%
Total Non-Current Liabilities
0.61
100.89
-100.28
-99.40%
Current Liabilities
Trade Payables
0.00
0.00
0.00
0.00%
Other Current Liabilities
1.15
0.00
1.15
0.00%
Short Term Borrowings
0.00
100.30
-100.30
-100.00%
Short Term Provisions
0.00
0.53
-0.53
-100.00%
Total Current Liabilities
1.15
102.73
-101.58
-98.88%
Total Liabilities
57.93
123.13
-65.20
-52.95%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
0.00
0.00
0.00%
Less: Accumulated Depreciation
0.00
0.00
0.00
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.00
0.00
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
42.29
0
42.29
0.00%
Long Term Loans & Advances
14.27
1.02
13.25
1,299.02%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
56.56
100.30
-43.74
-43.61%
Current Assets Loans & Advances
Current Investments
0.00
121.02
-121.02
-100.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.00
0.00
0.00%
Cash and Bank
0.01
1.10
-1.09
-99.09%
Other Current Assets
1.35
0
1.35
0.00%
Short Term Loans and Advances
0.00
0.00
0.00
0.00%
Total Current Assets
1.36
122.11
-120.75
-98.89%
Net Current Assets (Including Current Investments)
0.21
19.38
-19.17
-98.92%
Total Current Assets Excluding Current Investments
1.36
1.10
0.26
23.64%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
57.93
123.13
-65.20
-52.95%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.61
100.30
-99.69
-99.39%
Book Value per share (adjusted)
1.02
35.80
-34.78
-97.15%
Annual - Borrowings
Borrowings 0.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -68.72% vs 2.09% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
Investments 42.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.18% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 1.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is NA vs NA in Mar 2024






